PSMA6
Basic information
Region (hg38): 14:35278633-35317493
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PSMA6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 7 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 7 | 1 | 1 |
Variants in PSMA6
This is a list of pathogenic ClinVar variants found in the PSMA6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-35278712-C-T | PSMA6-related disorder | Benign (Nov 04, 2019) | ||
14-35292469-C-G | Myocardial infarction, susceptibility to • PSMA6-related disorder | Benign; risk factor (Oct 18, 2019) | ||
14-35292481-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
14-35292519-A-G | not specified | Uncertain significance (Dec 01, 2022) | ||
14-35292544-A-G | not specified | Uncertain significance (Oct 04, 2022) | ||
14-35308030-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
14-35308904-T-G | PSMA6-related disorder | Likely benign (Mar 22, 2019) | ||
14-35312899-T-C | not specified | Uncertain significance (May 24, 2023) | ||
14-35313018-G-A | not specified | Uncertain significance (Apr 18, 2023) | ||
14-35314427-G-A | not specified | Uncertain significance (Nov 03, 2022) | ||
14-35317256-A-G | not specified | Uncertain significance (Sep 04, 2024) | ||
14-35317287-C-G | not specified | Uncertain significance (Mar 04, 2024) | ||
14-35317289-C-G | not specified | Uncertain significance (Sep 11, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PSMA6 | protein_coding | protein_coding | ENST00000261479 | 7 | 38861 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.986 | 0.0138 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.41 | 53 | 130 | 0.407 | 0.00000598 | 1606 |
Missense in Polyphen | 11 | 35.42 | 0.31056 | 417 | ||
Synonymous | -0.663 | 50 | 44.4 | 1.13 | 0.00000216 | 460 |
Loss of Function | 3.34 | 0 | 13.0 | 0.00 | 5.44e-7 | 173 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex). {ECO:0000269|PubMed:15244466, ECO:0000269|PubMed:27176742, ECO:0000269|PubMed:8610016}.;
- Pathway
- Proteasome - Homo sapiens (human);Proteasome Degradation;TLR NFkB;proteasome complex;B cell receptor signaling;Post-translational protein modification;Metabolism of proteins;DroToll-like;Notch;Hedgehog;IL-1 NFkB;IL-1 p38;IL-1 JNK;TGF-beta super family signaling pathway canonical;TLR p38;UCH proteinases;Neddylation;Ub-specific processing proteases;JAK STAT pathway and regulation;Deubiquitination;TLR JNK;TNF;Wnt Canonical;Wnt Mammals;CD4 T cell receptor signaling-NFkB cascade;CD4 T cell receptor signaling
(Consensus)
Recessive Scores
- pRec
- 0.388
Intolerance Scores
- loftool
- 0.110
- rvis_EVS
- -0.01
- rvis_percentile_EVS
- 53.19
Haploinsufficiency Scores
- pHI
- 0.988
- hipred
- Y
- hipred_score
- 0.794
- ghis
- 0.521
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.999
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Low | Low | Low |
Primary Immunodeficiency | Low | Low | Low |
Cancer | Low | Low | Low |
Mouse Genome Informatics
- Gene name
- Psma6
- Phenotype
Gene ontology
- Biological process
- proteasomal protein catabolic process;proteasomal ubiquitin-independent protein catabolic process;protein deubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification;regulation of inflammatory response;positive regulation of NF-kappaB transcription factor activity;proteolysis involved in cellular protein catabolic process
- Cellular component
- proteasome complex;P-body;nucleus;nucleoplasm;cytoplasm;cytosol;proteasome core complex;polysome;nuclear matrix;proteasome core complex, alpha-subunit complex;myofibril;sarcomere;extracellular exosome
- Molecular function
- RNA binding;endopeptidase activity;threonine-type endopeptidase activity;protein binding;purine ribonucleoside triphosphate binding;NF-kappaB binding